Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization
Trial Parameters
Brief Summary
Effects of Antrodia cinnamomea on the hepatoma patients after Transcatheter hepatic artery chemoembolization
Eligibility Criteria
Inclusion Criteria: * Sign the informed consent form * Aged between 20 and 80 * Child-Pugh score class A, B * Serum bilirubin level ≤ 1.5 times the upper limit of normal, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels ≤ 2 times the upper limit of normal Exclusion Criteria: * Unwillingness to sign the informed consent form * Child-Pugh score class C * Patients with main portal vein thrombosis * Patients with diffuse liver tumors * Those who are allergic to the contrast medium * Those with abnormal coagulation function * Those with severe dysfunction of brain, heart and lung * Patients with severe renal dysfunction (except those receiving renal dialysis) * Unable to cooperate * Those with uncontrolled arrhythmia and unstable blood pressure * Some patients with abnormal thyroid function * Any other contraindications such as active gastrointestinal bleeding, refractory ascites, or severe portal hypertension * Pregnant or lactating women